Skip to main content
MS-DRG 916 · MDC 21 · Medical

MS-DRG 916: Allergic Reactions without MCC

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 916

FY2027 relative weight
0.6928
Higher than 5% of all MS-DRGs
Change vs FY2026
+4.0%
FY2026 weight 0.6663
Geometric mean LOS
1.8 days
Arithmetic mean 2.2 days
MDC
21
Injuries, Poisonings and Toxic Effects of Drugs
Severity level
without MCC
National unadjusted operating payment
$4,744.29
Weight × $6,848.00 FY2027 standardized amount; capital adds $374.08
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 916 is a medical group in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs), at the lower of two severity levels (no MCC present). CMS assigns it a FY2027 relative weight of 0.6928 with a geometric mean length of stay of 1.8 days and an arithmetic mean of 2.2. Its weight moved up 4.0% from FY2026 (0.6663). That weight is higher than 5% of all MS-DRGs. Its weight sits 58.2% below DRG 915 (with MCC, 1.6558). The v44 Definitions Manual assigns it through 25 principal diagnosis codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 916 the FY2027 relative weight is 0.6928 against 0.6663 in FY2026, a rise of 3.98%, which exceeds the 2% threshold worth re-checking in contract models.

FY2026 versus FY2027 payment factors for MS-DRG 916
MetricFY2026FY2027Change
Relative weight0.66630.6928+0.0265
Geometric mean LOS (days)1.81.8+0.0
Arithmetic mean LOS (days)2.22.2+0.0
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 916 shares its base definition with 1 other MS-DRG split by severity. The family's weights span 0.6928 to 1.6558, a 2.39× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 916
DRGTitleFY2027 weightGMLOSNational operating payment
915Allergic Reactions with MCC1.65583.4$11,338.92
916Allergic Reactions without MCC0.69281.8$4,744.29

At the national rate, documenting the family's top severity level (DRG 915, $11,338.92) instead of its base level (DRG 916, $4,744.29) changes the operating payment by $6,594.62, the amount at stake when a qualifying secondary diagnosis goes undocumented. The figures are national operating amounts before the hospital-specific adjustments described below.

National unadjusted payment for DRG 916

Multiplying the FY2027 relative weight (0.6928) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $6,594.62.

FY2027 national unadjusted IPPS payment for MS-DRG 916
ComponentNational rateDRG 916
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$4,744.29
Capital (federal rate)$539.95$374.08
Operating plus capital$5,118.37
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $4,595.89 to $4,707.19 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 916.

Grouper logic (v44 Definitions Manual)

The manual's split table for Allergic Reactions gives one row per combination of criteria and the MS-DRG it assigns. DRG 916 is the row where MCC is No.

Split table for Allergic Reactions
MCCDRG
Yes915
No916

Principal Diagnosis: 25 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.

Principal Diagnosis codes in the logic for DRG 916 (sample)
ICD-10-CM codeDescription
T78.00XAAnaphylactic reaction due to unspecified food, initial encounter
T78.01XAAnaphylactic reaction due to peanuts, initial encounter
T78.02XAAnaphylactic reaction due to shellfish (crustaceans), initial encounter
T78.03XAAnaphylactic reaction due to other fish, initial encounter
T78.04XAAnaphylactic reaction due to fruits and vegetables, initial encounter
T78.05XAAnaphylactic reaction due to tree nuts and seeds, initial encounter
T78.06XAAnaphylactic reaction due to food additives, initial encounter
T78.070AAnaphylactic reaction due to milk and dairy products with tolerance to baked milk, initial encounter
T78.071AAnaphylactic reaction due to milk and dairy products with reactivity to baked milk, initial encounter
T78.079AAnaphylactic reaction due to milk and dairy products, unspecified, initial encounter
T78.080AAnaphylactic reaction due to egg with tolerance to baked egg, initial encounter
T78.081AAnaphylactic reaction due to egg with reactivity to baked egg, initial encounter

Code editor, HAC and CC/MCC exclusion notes for DRG 916

Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 916

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 916

What is MS-DRG 916?

MS-DRG 916 is "Allergic Reactions without MCC", a medical Medicare Severity Diagnosis-Related Group in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 916?

The FY2027 relative weight is 0.6928 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 0.6663, a change of +4.0%.

What is the Medicare base payment for MS-DRG 916?

$4,744.29 for operating costs plus $374.08 for capital, $5,118.37 together, at the FY2027 national rates: weight 0.6928 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 915 (with MCC) comes to $11,338.92 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 916?

CMS reports a geometric mean length of stay of 1.8 days and an arithmetic mean of 2.2 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 916?

DRG 915 (with MCC, weight 1.6558, GMLOS 3.4 days). Together with DRG 916 the family spans 0.6928 to 1.6558, a 2.39x spread, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 916?

DRG 916 is the lower level of a two-way MCC split: no secondary diagnosis on the CMS MCC list was coded, and CCs alone do not change the group. Review here looks for MCC-level conditions treated during the stay but not documented to the required specificity, such as acute respiratory failure, severe protein-calorie malnutrition or septic shock; a compliant query to the attending is the only way to move the stay to the MCC sibling.

Which codes group to DRG 916?

The v44 Definitions Manual lists 25 principal diagnosis codes for this group. Examples from the principal diagnosis list, T78.00XA (Anaphylactic reaction due to unspecified food, initial encounter); T78.01XA (Anaphylactic reaction due to peanuts, initial encounter); T78.02XA (Anaphylactic reaction due to shellfish (crustaceans), initial encounter); T78.03XA (Anaphylactic reaction due to other fish, initial encounter).

Is DRG 916 a post-acute transfer DRG?

No. DRG 916 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.